Pesquisas alternativas:
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
devel ther » level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug deal » drugs deal (Expandir a Pesquisa), drug dealer (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
drug dev » drug diet (Expandir a Pesquisa), drug demo (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
devel ther » level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug deal » drugs deal (Expandir a Pesquisa), drug dealer (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
drug dev » drug diet (Expandir a Pesquisa), drug demo (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
161
Por Scott, David R., Munson, Keith B., Marcus, Elizabeth A., Lambrecht, Nils W. G., Sachs, George
Publicado no Aliment Pharmacol Ther (2015)
“... recently, the only drugs that effectively inhibited this ATPase were the proton pump inhibitors (PPIs...”Publicado no Aliment Pharmacol Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
162
Por Lambert, Olivier, Bandilla, Dirk, Iyer, Rupa, Witchey-Lakshmanan, Leonore, Palepu, Nagesh
Publicado em 2012
“... tested for up to 14 days. CONCLUSIONS: Epoprostenol AM has improved thermal stability and does...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
163
Por Chen, Wenxue, Bardhan, Rizia, Bartels, Marc, Perez-Torres, Carlos, Pautler, Robia G., Halas, Naomi J., Joshi, Amit
Publicado em 2010
“... expression does not usually affect the survival rates of ovarian cancer to the same extent as in breast...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
164
“... are urgently needed. As our understanding of the underlying dysfunction of the myocardium increases, so does...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
165
Por Kellinghaus, Christoph
Publicado em 2009
“...Lacosamide (LCM) is a novel agent that has been developed as an antiepileptic drug. In vitro...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Artigo
166
“...Safinamide (SAF) is a new drug developed for the treatment of Parkinson’s disease (PD). It is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
167
“..., and does not permit cross-resistance to direct-acting antivirals. Alisporivir has an excellent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
168
Por Doupis, John
Publicado em 2014
“... preclinical profile, linagliptin is unique among available dipeptidyl peptidase-4 compounds because it does...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
169
Por Blandizzi, Corrado, Viscomi, Giuseppe Claudio, Scarpignato, Carmelo
Publicado no Drug Des Devel Ther (2014)
“... not serious and not related to the study medications. CONCLUSION: Rifaximin-α, a crystal polymorph, does...”Publicado no Drug Des Devel Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
170
“...). CONCLUSION: Aliskiren therapy does not have an effect on the incidence of major cardiovascular events, total...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
171
Por Kim, Hyungsub, Choi, Hee Youn, Kim, Yo-Han, Bae, Kyun-Seop, Jung, Jina, Son, Hankil, Lim, Hyeong-Seok
Publicado no Drug Des Devel Ther (2018)
“... that effectively reduces low-density lipoprotein cholesterol levels. However, statin monotherapy does not always...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
172
“... patients. Today, imatinib is the first-line treatment for CML. However, imatinib does not appear...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
173
Por Broichhausen, Christiane, Riquelme, Paloma, Ahrens, Norbert, Wege, Anja K, Koehl, Gudrun E, Schlitt, Hans J, Banas, Bernhard, Fändrich, Fred, Geissler, Edward K, Hutchinson, James A
Publicado no Mol Ther Methods Clin Dev (2014)
“... been developed and conforms to expectations of a therapeutic drug. Here, Mreg_UKR was subjected...”Publicado no Mol Ther Methods Clin Dev (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
174
“... the gastrointestinal tract of glycyrrhizic acid diethyl ester (GZ-DE) which was prepared as a prodrug of glycyrrhizic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
175
“... and does not support the growth of any micro-organism tested for up to 17 days. This extended stability...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
176
Por Hoch, Matthias, Darpo, Borje, Remenova, Tatiana, Stoltz, Randall, Zhou, Meijian, Kaufmann, Priska, Bruderer, Shirin, Dingemanse, Jasper
Publicado no Drug Des Devel Ther (2014)
“... but, in contrast, a positive slope within the expected range for moxifloxacin. In conclusion, selexipag does...”Publicado no Drug Des Devel Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
177
Por Guo, Yan, Sun, Juan, Ye, Juan, Ma, Wenyu, Yan, Hualing, Wang, Gang
Publicado no Drug Des Devel Ther (2016)
“... irradiation; however, this effect does not occur via the p38MAPK pathway....”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
178
Por Darkovska-Serafimovska, Marija, Janevik-Ivanovska, Emilija, Djorgoski, Icko, Arsova-Sarafinovska, Zorica, Zdravkovska, Milka, Balkanov, Trajan, Ugresic, Nenad
Publicado no Drug Des Devel Ther (2016)
“... of tirofiban does not affect its ability to bind to glycoprotein IIb/IIIa or its in vivo pharmacokinetics...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
179
Por Rapoport, Bernardo Leon, Aapro, Matti, Chasen, Martin R, Jordan, Karin, Navari, Rudolph M, Schnadig, Ian, Schwartzberg, Lee
Publicado no Drug Des Devel Ther (2017)
“... and netupitant, rolapitant does not inhibit or induce CYP3A4. However, rolapitant is a moderate inhibitor of CYP2...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
180
Por Tomatsu, Shunji, Sawamoto, Kazuki, Alméciga-Díaz, Carlos J, Shimada, Tsutomu, Bober, Michael B, Chinen, Yasutsugu, Yabe, Hiromasa, Montaño, Adriana M, Giugliani, Roberto, Kubaski, Francyne, Yasuda, Eriko, Rodríguez-López, Alexander, Espejo-Mojica, Angela J, Sánchez, Oscar F, Mason, Robert W, Barrera, Luis A, Mackenzie, William G, Orii, Tadao
Publicado no Drug Des Devel Ther (2015)
“... seems to be enhanced in a mouse model of MPS IVA by a novel form of the enzyme tagged with a bone...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo